Profile data is unavailable for this security.
About the company
Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.
- Revenue in USD (TTM)89.38bn
- Net income in USD3.14bn
- Incorporated1964
- Employees95.50k
- LocationHumana Inc500 W Main StLOUISVILLE 40202United StatesUSA
- Phone+1 (502) 580-1000
- Fax+1 (302) 636-5454
- Websitehttp://www.humana.com/
Mergers & acquisitions
| Acquired company | HUM:NYQ since announced | Transaction value |
|---|---|---|
| Inclusa Inc | 2.39% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc | 10.58bn | 1.48bn | 16.23bn | 40.00k | 11.73 | 2.57 | 8.67 | 1.55 | 12.02 | 12.02 | 86.38 | 54.79 | 0.8086 | 34.16 | 8.31 | 264,550.00 | 11.29 | 9.41 | 12.95 | 10.91 | 37.71 | 37.56 | 13.96 | 13.22 | 1.42 | 14.78 | 0.3791 | 25.15 | 14.32 | 7.50 | 39.51 | 25.36 | 6.58 | 8.90 |
| Molina Healthcare, Inc. | 30.27bn | 752.00m | 19.00bn | 14.00k | 25.69 | 6.76 | 21.22 | 0.6329 | 12.83 | 12.83 | 516.38 | 48.79 | 2.62 | -- | 14.78 | 2,162,357.00 | 6.51 | 5.55 | 14.79 | 12.93 | 14.62 | 15.86 | 2.48 | 2.25 | -- | 10.48 | 0.458 | 0.00 | 42.98 | 9.33 | -2.08 | 66.18 | -15.24 | -- |
| Laboratory Corp. of America Holdings | 15.72bn | 1.99bn | 22.86bn | 75.50k | 12.40 | 2.27 | 8.72 | 1.49 | 20.89 | 20.89 | 165.38 | 114.29 | 0.77 | 24.72 | 5.34 | 208,148.30 | 9.76 | 7.25 | 11.23 | 8.42 | 32.56 | 31.75 | 12.68 | 10.12 | 1.74 | 26.52 | 0.3436 | -- | 15.33 | 11.03 | 52.77 | 27.28 | 10.54 | -- |
| Centene Corp | 138.10bn | 1.86bn | 54.97bn | 72.50k | 30.16 | 2.10 | 16.17 | 0.3983 | 3.14 | 3.14 | 234.40 | 45.24 | 1.81 | -- | -- | 1,904,759.00 | 2.43 | 2.84 | -- | -- | -- | -- | 1.34 | 1.43 | -- | 6.36 | 0.4139 | 0.00 | 13.38 | 25.41 | -25.50 | 19.23 | 24.36 | -- |
| HCA Healthcare Inc | 60.11bn | 6.51bn | 60.30bn | 204.00k | 10.42 | -- | 6.08 | 1.03 | 20.80 | 20.80 | 193.46 | -12.82 | 1.21 | 4.67 | 7.39 | 294,632.30 | 14.68 | 10.99 | 18.96 | 14.26 | 84.20 | 83.58 | 12.18 | 9.18 | 1.32 | 6.04 | 1.03 | 9.16 | 14.01 | 7.21 | 85.30 | 19.20 | 5.32 | -- |
| Humana Inc | 89.38bn | 3.14bn | 61.73bn | 95.50k | 19.83 | 3.97 | 15.67 | 0.6881 | 24.51 | 24.51 | 697.73 | 122.40 | 2.11 | -- | -- | 935,947.60 | 7.39 | 8.68 | -- | -- | -- | -- | 3.51 | 3.92 | -- | 9.44 | 0.4602 | 11.05 | 7.66 | 8.84 | -12.89 | 36.72 | 20.09 | 19.27 |
| Cigna Corp | 179.18bn | 5.48bn | 86.97bn | 73.70k | 17.12 | 1.97 | 10.32 | 0.4888 | 16.77 | 16.77 | 548.51 | 145.37 | 1.17 | -- | -- | 2,431,248.00 | 3.61 | 3.81 | -- | -- | -- | -- | 3.09 | 4.17 | -- | 7.09 | 0.4207 | 5.81 | 8.69 | 34.43 | -36.57 | 23.51 | 20.14 | 151.19 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2022 | 10.52m | 8.31% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2022 | 8.79m | 6.95% |
| Wellington Management Co. LLPas of 31 Mar 2022 | 8.78m | 6.94% |
| BlackRock Fund Advisorsas of 30 Jun 2022 | 5.85m | 4.62% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 5.66m | 4.47% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2022 | 5.58m | 4.41% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2022 | 4.16m | 3.29% |
| Capital Research & Management Co. (International Investors)as of 31 Mar 2022 | 3.35m | 2.65% |
| Harris Associates LPas of 31 Mar 2022 | 3.07m | 2.42% |
| Geode Capital Management LLCas of 30 Jun 2022 | 2.10m | 1.66% |
